"Almost all of the 41 million estimated contact lens wearers in the United States may be engaging in at least one behavior known to increase their risk of eye infections, according to a report published today by the Centers for Disease Control and"...
(levobetaxolol hydrochloride) Ophthalmic Suspension 0.5%
Sterile Topical Ophthalmic Drops
BETAXON™ (levobetaxolol hydrochloride ophthalmic suspension) 0.5% contains levobetaxolol hydrochloride, a cardioselective beta-adrenergic receptor blocking agent, in a sterile resin suspension formulation. Levobetaxolol hydrochloride is a white, crystalline powder with a molecular weight of 343.89. The specific rotation is:
[α]25°C/589nm -19.67°(c=20 mg/mL; methanol)
The chemical structure is:
Empirical Formula: C18H29NO3•HCl
Chemical Name: (S)-1-[p-[2-(cyclopropylemethoxy)ethyl]phenoxy]3-(isopropylamino)-2-propanol hydrochloride.
Each mL of BETAXON™ (levobetaxolol hydrochloride ophthalmic suspension) 0.5% contains: Active: levobetaxolol HCl 5.6 mg equivalent to 5.0 mg of levobetaxolol free base. Preservative: benzalkonium chloride 0.01%. Inactives: mannitol, poly(styrene-divinyl benzene) sulfonic acid, Carbomer 974P, boric acid, N-lauroylsarcosine, edetate disodium, hydrochloric acid or tromethamine (to adjust pH) and purified water. It has a pH of 5.5 to 7.5 and an osmolality of 260 to 340 mOsm per kg.
Last reviewed on RxList: 3/30/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Betaxon Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.